Profile

PhD, Ludwig-Maximilians-Universität München




DEVELOPMENT OF TUMOR STROMA-DIRECTED THERAPIES
05/01/2015 - 04/30/2019 (PI)
Department of Defense/Army Medical Research Acquisition Activity

LYSYL OXIDASE PROPEPTIDE: BREAST CANCER INHIBITOR
04/12/2010 - 01/31/2016 (PI)
NIH/National Cancer Institute NIH NCI
R01CA143108

DEVELOPMENT OF INHIBITORS TARGETING P130CAS/BCAR1 FAMILY PROTEINS
08/09/2010 - 02/08/2014 (PI)
Susan G. Komen for the Cure

Lysyl Oxidase Inhibition of Ras-Mediated Transformation
09/01/1999 - 04/30/2010 (Co-PI)
NIH/National Cancer Institute
5 R01 CA82742 10

Molecular and Transgenic Analysis of the Adapter Protein p130Cas/BCAR1 in Normal and Cancerous Mammary Gland
03/01/2006 - 12/31/2009 (Dept Sponsor)
Department of Defense/Army

The Role of p130Cas in Sporadic Breast Cancer
04/01/2005 - 09/30/2005 (Dept Sponsor)
American Foundation for Aging Research

Molecular Mechanisms in Kidney Function and Disease
02/01/2002 - 03/31/2004 (PI)
March of Dimes



Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. de la Cueva A, Emmerling M, Lim SL, Yang S, Trackman PC, Sonenshein GE, Kirsch KH. A polymorphism in the lysyl oxidase propeptide domain accelerates carcinogen-induced cancer. Carcinogenesis. 2018 Jul 03; 39(7):921-930.View Related Profiles. PMID: 29579155.
     
  2. Sánchez-Morgan N, Kirsch KH, Trackman PC, Sonenshein GE. UXT Is a LOX-PP Interacting Protein That Modulates Estrogen Receptor Alpha Activity in Breast Cancer Cells. J Cell Biochem. 2017 Aug; 118(8):2347-2356.View Related Profiles. PMID: 28106301; DOI: 10.1002/jcb.25893;.
     
  3. Kumbrink J, de la Cueva A, Soni S, Sailer N, Kirsch KH. A truncated phosphorylated p130Cas substrate domain is sufficient to drive breast cancer growth and metastasis formation in vivo. Tumour Biol. 2016 Aug; 37(8):10665-73.View Related Profiles. PMID: 26867768; DOI: 10.1007/s13277-016-4902-8;.
     
  4. Rouka E, Simister PC, Janning M, Kumbrink J, Konstantinou T, Muniz JR, Joshi D, O'Reilly N, Volkmer R, Ritter B, Knapp S, von Delft F, Kirsch KH, Feller SM. Differential Recognition Preferences of the Three Src Homology 3 (SH3) Domains from the Adaptor CD2-associated Protein (CD2AP) and Direct Association with Ras and Rab Interactor 3 (RIN3). J Biol Chem. 2015 Oct 16; 290(42):25275-92.View Related Profiles. PMID: 26296892; PMCID: PMC4646179; DOI: 10.1074/jbc.M115.637207;.
     
  5. Kumbrink J, Soni S, Laumbacher B, Loesch B, Kirsch KH. Identification of Novel Crk-associated Substrate (p130Cas) Variants with Functionally Distinct Focal Adhesion Kinase Binding Activities. J Biol Chem. 2015 May 8; 290(19):12247-55.View Related Profiles. PMID: 25805500; PMCID: PMC4424356; DOI: 10.1074/jbc.M115.649947;.
     
  6. Sato S, Zhao Y, Imai M, Simister PC, Feller SM, Trackman PC, Kirsch KH, Sonenshein GE. Inhibition of CIN85-mediated invasion by a novel SH3 domain binding motif in the lysyl oxidase propeptide. PLoS One. 2013; 8(10):e77288.View Related Profiles. PMID: 24167568; PMCID: PMC3805583; DOI: 10.1371/journal.pone.0077288;.
     
  7. Chen CH, Ho YC, Ho HH, Chang IC, Kirsch KH, Chuang YJ, Layne MD, Yet SF. Cysteine-rich protein 2 alters p130Cas localization and inhibits vascular smooth muscle cell migration. Cardiovasc Res. 2013 Dec 1; 100(3):461-71.View Related Profiles. PMID: 23975851; PMCID: PMC3826702; DOI: 10.1093/cvr/cvt207;.
     
  8. Chakrabarti P, Kim JY, Singh M, Shin YK, Kim J, Kumbrink J, Wu Y, Lee MJ, Kirsch KH, Fried SK, Kandror KV. Insulin inhibits lipolysis in adipocytes via the evolutionarily conserved mTORC1-Egr1-ATGL-mediated pathway. Mol Cell Biol. 2013 Sep; 33(18):3659-66.View Related Profiles. PMID: 23858058; PMCID: PMC3753874; DOI: 10.1128/MCB.01584-12;.
     
  9. Zhao Y, Kumbrink J, Lin BT, Bouton AH, Yang S, Toselli PA, Kirsch KH. Expression of a phosphorylated substrate domain of p130Cas promotes PyMT-induced c-Src-dependent murine breast cancer progression. Carcinogenesis. 2013 Dec; 34(12):2880-90.View Related Profiles. PMID: 23825155; PMCID: PMC3845889; DOI: 10.1093/carcin/bgt238;.
     
  10. Kumbrink J, Kirsch KH. p130Cas acts as survival factor during PMA-induced apoptosis in HL-60 promyelocytic leukemia cells. Int J Biochem Cell Biol. 2013 Mar; 45(3):531-5.View Related Profiles. PMID: 23287717; DOI: 10.1016/j.biocel.2012.12.017;.
     
Showing 10 of 40 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.


Contact for Mentoring: